ABT vs COMP · P/E 25, rev $44.33B vs rev $5.63B
Abbott Laboratories (ABT) versus Compass Inc (COMP) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Compass Inc (COMP) is a real estate services company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported COMP revenue for 2024-12-31 was $5.63B. Net income was -$154.5M. Revenue was up 15.2% from 2023-12-31 to 2024-12-31. COMP currently screens at market cap $3.35B.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. COMP currently screens at market cap $3.35B.
Not investment advice. Open the ABT and COMP stock pages for the full models.
Not investment advice.